Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory, Single-center, Two-part Study to Characterize Cutaneous Lupus Erythematosus and Investigate the Effect of an Immune Challenge by Comparing CLE Patients With Healthy Volunteers

NCT06411106 is registered in ClinicalTrials.gov with Centre for Human Drug Research, Netherlands as lead sponsor.

NCT NCT06411106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06411106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory, Single-center, Two-part Study to Characterize Cutaneous Lupus Erythematosus and Investigate the Effect of an Immune Challenge by Comparing CLE Patients With Healthy Volunteers
Lead sponsor
Centre for Human Drug Research, Netherlands
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2024
Completion date
September 30, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous lupus erythematosus